Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 49
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
4/1/1988
1.
Phase II/III Study of IFN-beta-ser/IFN-gamma Followed by DDP/VP-16 in Patients with Inoperable non-Small Cell Lung Cancer (Summary Last Modified 04/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
18 and over
WCCC-CO-8751
NCI-V87-0225
Last Modified:
9/1/2002
2.
Phase III Randomized Study of Conventional Radiotherapy with vs without IFN-B in Patients with Locally Advanced non-Small Cell Lung Cancer (Summary Last Modified 09/02)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
NCI
RTOG-9304
RTOG-93-04
3.
Pilot Phase I-II Evaluation of Human Fibroblast Interferon for Disseminated Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
no age specified
MDA-MBDT-7866
Last Modified:
7/1/1996
4.
Phase I/II Study of Radiotherapy with IFN-B Radiosensitization for Malignant Glioma (Summary Last Modified 07/96)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
Other
URCC-4393MR
NCI-V94-0600
5.
Phase I-II Immunotherapy with Human Leukocyte & Fibroblast Interferon for Breast, Bronchogenic, and Colon Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
16 to 75
WCCC-CO-8091
6.
Phase I/II Immunotherapy with Intravesicular Beta-Interferon in Patients with Recurrent Superficial Bladder Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
NBCG-17
Last Modified:
3/1/1988
7.
Phase I/II Study of Intraventricular IFN-beta-ser in Patients with Carcinomatous Meningitis (Summary Last Modified 03/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
UAB-387
NCI-V87-0160
Last Modified:
8/1/1993
8.
Phase I/II Pilot Study of Intravenous IFN-B and Hyperfractionated Radiotherapy in Children with Newly Diagnosed Brainstem Gliomas (Summary Last Modified 08/93)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
2 to 18
NCI
CCG-0912
CCG-0912
Last Modified:
12/1/2001
9.
Phase II Study of Recombinant Human Interferon Beta-1a (Avonex) in Patients with Recurrent Gliomas or Astrocytomas (Summary Last Modified 12/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
MDA-NCNSC-96314
NCI-T94-0125, T94-0125
Last Modified:
9/20/2007
 
First Published:
5/1/1998
10.
Phase II Study of Radiotherapy Followed by Recombinant Interferon Beta in Patients with Supratentorial Glioblastoma Multiforme
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
RTOG-9710
RTOG-97-10
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute